Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEDOM COVID Anticoagulation Strategy
NCT04512079Phase 4Completed
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of apixaban in coronavirus disease 2019 (COVID-19). Started Sep 2020; status: completed.
02
Drugs
apixaban
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04512079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512079.